University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Dorie Apollonio, MPP, PhD

Dorie Apollonio, MPP, PhD

Assistant Adjunct Professor, Department of Clinical Pharmacy, UCSF

Cancer Center Program Memberships

Tobacco Control

Research Summary

Dr. Dorie Apollonio is an Associate Professor of health policy in the Department of Clinical Pharmacy at the University of California, San Francisco focusing on tobacco control and policy making. Her research considers the role of scientific evidence and interest group lobbying in decision making on public health. This work uses multiple data sources including internal industry documents, campaign finance reports, administrative datasets, and interviews, and relies on both qualitative and quantitative methods to identify how policy affecting public health is made. She is trained as a quantitative methodologist and survey researcher and has extensive experience in research design and analysis. Her work has been published in peer-reviewed journals in multiple fields, including public health, political science, policy, and law.

Education

Macalester College, St. Paul, MN, BA, 1992, Political Science, History
Harvard Kennedy School, Cambridge, MA, MPP, 1994, Health Policy
University of California, Berkeley, CA, PhD, 2003, Political Science
University of California, San Francisco, CA, Postdoctoral, 2003-2006, Health Policy
 


Professional Experience

  • 1993
    Research Analyst and Interviewer, Seattle-King County Department of Public Health, Seattle-Area Needle Exchange and AIDS Prevention Unit
  • 1993-1994
    Graduate Student Instructor, Harvard Kennedy School
  • 1994-2002
    Graduate Student Researcher, UC Berkeley
  • 1998-2000
    Statistical Consultant, Pacific Gas & Electric Dynamic Load Profiling Group
  • 2002-2003
    Survey Research Associate, Public Policy Institute of California
  • 2003-2005
    Postdoctoral Fellow, UCSF School of Medicine
  • 2005-2006
    Postdoctoral Fellow, UCSF Schools of Pharmacy and Nursing
  • 2006-present
    Assistant Professor, UCSF School of Pharmacy

Honors & Awards

  • 1995
    Henry Robert Braden Fellowship, UC Berkeley
  • 2000-2001
    Graduate Dissertation Fellowship, UC Berkeley
  • 2003-2005
    American Legacy Foundation Fellowship, UCSF School of Medicine
  • 2005
    Certificate in Health Services Research, UCSF School of Medicine
  • 2008
    Academic Senate Travel Grant, UCSF
  • 2008
    Dean's Recognition for Excellence in Teaching Award, UCSF School of Pharmacy
  • 2009
    Regulation and Governance Prize for the best article published in the journal in 2007 or 2008

Selected Publications

  1. Huey J, Apollonio DE. A content analysis of popular media reporting regarding increases in minimum ages of legal access for tobacco. BMC Public Health. 2018 Sep 17; 18(1):1129.
    View on PubMed
  2. Apollonio DE, Glantz SA. Marketing with tobacco pack onserts: a qualitative analysis of tobacco industry documents. Tob Control. 2018 Jun 28.
    View on PubMed
  3. Kearns C, Schmidt L, Apollonio D, Glantz S. The sugar industry's influence on policy. Science. 2018 05 04; 360(6388):501.
    View on PubMed
  4. Kearns CE, Apollonio D, Glantz SA. Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: An historical analysis of internal documents. PLoS Biol. 2017 Nov; 15(11):e2003460.
    View on PubMed
  5. Apollonio D, Glantz SA. Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us". Am J Public Health. 2017 Oct; 107(10):1636-1642.
    View on PubMed
  6. Sung H, Apollonio DE. Evaluation of Tobacco Control Policies in San Francisco Homeless Housing Programs. Health Promot Pract. 2017 Jul; 18(4):571-580.
    View on PubMed
  7. Apollonio DE, Bero LA. Interpretation and use of evidence in state policymaking: a qualitative analysis. BMJ Open. 2017 02 20; 7(2):e012738.
    View on PubMed
  8. Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev. 2016 11 23; 11:CD010274.
    View on PubMed
  9. Apollonio DE, Wolfe N, Bero LA. Realist review of policy intervention studies aimed at reducing exposures to environmental hazards in the United States. BMC Public Health. 2016 08 18; 16(1):822.
    View on PubMed
  10. Apollonio DE, Bero LA. Challenges to generating evidence-informed policy and the role of systematic reviews and (perceived) conflicts of interest. Journal of Communication in Healthcare. 2016; 2(9):135-141.
    View on PubMed
  11. Apollonio DE, Bero LA. Challenges to generating evidence-informed policy and the role of systematic reviews and (perceived) conflicts of interest. J Commun Healthc. 2016; 9(2):135-141.
    View on PubMed
  12. Apollonio DE, Glantz SA. Minimum Ages of Legal Access for Tobacco in the United States From 1863 to 2015. Am J Public Health. 2016 Jul; 106(7):1200-7.
    View on PubMed
  13. Krauth D, Apollonio DE. Overview of state policies requiring smoking cessation therapy in psychiatric hospitals and drug abuse treatment centers. Tob Induc Dis. 2015; 13:33.
    View on PubMed
  14. Krauth D, Apollonio D. Accuracy of popular media reporting on tobacco cessation therapy in substance abuse and mental health populations. BMJ Open. 2015 Mar 26; 5(3):e007169.
    View on PubMed
  15. Lochner T, Apollonio D. Karma Police: Prosecutorial Strategies in Obscenity Cases and the Broader Culture War. Syracuse Law Civ Engagem. 2014; 2.
    View on PubMed
  16. Apollonio DE. Political advocacy in pharmacy: challenges and opportunities. Integr Pharm Res Pract. 2014; 3:89-95.
    View on PubMed
  17. Apollonio DE, Glantz SA, Bero LA. Term limits and the tobacco industry. Soc Sci Med. 2014 Mar; 104:1-5.
    View on PubMed
  18. Apollonio D, Lochner T, Heddens M. Immigration and Prosecutorial Discretion. Calif J Politics Policy. 2013; 5(2):232-251.
    View on PubMed
  19. Apollonio D, Philipps R, Bero L. Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. Cochrane Libr. 2012 Dec 01; 12:1-10.
    View on PubMed
  20. Apollonio DE, Malone RE. The "We Card" program: tobacco industry "youth smoking prevention" as industry self-preservation. Am J Public Health. 2010 Jul; 100(7):1188-201.
    View on PubMed

Go to UCSF Profiles, powered by CTSI